Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Total Costs & Expenses Over TimeStable
Percentile Rank36
3Y CAGR-0.8%
5Y CAGR+5.9%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-0.8%/yr
vs -3.2%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
+2.4pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.34M | +17.3% |
| 2024 | $30.98M | -8.0% |
| 2023 | $33.68M | -9.5% |
| 2022 | $37.22M | -29.9% |
| 2021 | $53.11M | +95.1% |
| 2020 | $27.22M | -32.5% |
| 2019 | $40.35M | -4.9% |
| 2018 | $42.41M | -0.1% |
| 2017 | $42.45M | -30.7% |
| 2016 | $61.22M | - |